Skip to main content


Figure 5 | Diabetology & Metabolic Syndrome

Figure 5

From: Neuroendocrine and metabolic components of dopamine agonist amelioration of metabolic syndrome in SHR rats

Figure 5

Impact of timed daily bromocriptine or vehicle administration on humoral modulators of metabolism and inflammation – plasma CRP (Panel A), plasma leptin (Panel B), plasma adiponectin (Panel C), and plasma norepinephrine (Panel D). Values are means ± SEM of 8 animals in each group. *Difference is statistically significant; P values are noted under each panel.

Back to article page